Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

CRTD receives 1.56 Mill. Euro BMBF-funding for retinal disease research

24.05.2017

The research groups lead by Prof. Dr. Elly Tanaka, Prof. Dr. Marius Ader and Dr. Mike Karl at the DFG-Research Center for Regenerative Therapies Dresden (CRTD) – Cluster of Excellence at TU Dresden, have received funding in the BMBF program “Validation of the technological and societal innovation potential of scientific research – VIP+” with their CLEANSIGHT research team. The research project will focus on validating a retinal cell–based screening platform for fast and efficient identification of small molecules for the treatment of retinal degenerative diseases.

With more than 150 million affected people, retinal degenerative diseases are one of the most frequent causes of visual impairment worldwide. Examples include genetically inherited Retinitis Pigmentosa (RP), and age-related macular degeneration (AMD). The prevalence of AMD is expected to reach epidemic proportions due to an increasingly aging population. There are currently no effective therapies to prevent or cure these diseases.


Retinal pigment epithelial cell culture & Cleansight team (left to right): Prof. Dr. Elly Tanaka, Prof. Dr. Marius Ader, Dr. Mike Karl, Dr. Seba Almedawar, Dr. Sven Schreiter & Dr. Dominic Eberle

© CRTD, Dominic Eberle

Retinal diseases are associated with build-up of waste products. Vision loss may occur, for example, when the retinal pigment epithelial cells (RPE), which underlie the neural retina, are impaired in taking up and recycling natural waste products of the retina.

This process, known as phagocytosis, is essential for visual function and survival of our light sensitive retinal neurons, called photoreceptors. Abnormal RPE cell function can lead to retinal degeneration, visual impairment and even loss of sight. Therapeutic compounds modulating RPE functions might prevent vision loss.

”The aim of CLEANSIGHT is to validate a RPE-based screening platform, which we have developed since 2013, to search for classes of compounds that are suitable candidates for the development of novel therapeutics, and bring it to industry standards. RPE cells used in this platform are derived from human stem cells by a patented and very efficient protocol, which made the platform development possible”, explains the research team consisting of Dr. Seba Almedawar (project leader), Dr. Sven Schreiter and Dr. Dominic Eberle, supported by Prof. Elly Tanaka, Prof. Marius Ader and Dr. Mike Karl. A procedure patented by Prof. Tanaka enables the production of large quantities of human RPE cells at uniformly high quality in the laboratory. This constitutes a major advance for the development of a screening platform for new therapeutic substances.

The awarded research grant is part of the new Hightech-Strategy „Innovationen für Deutschland“ of the German Federal Government. The rapid transfer of innovative ideas for products and services aims to strengthen Germany’s leading position as the largest national economy and exporter in Europe.

The Grant Office, CMCB (a service unit that supports CRTD, BIOTEC and B CUBE in the acquisition of third-party funds) and the Technology Transfer Office have both closely coordinated the CLEANSIGHT grant application and continue to offer their support to the project team.

Further information on CLEANSIGHT (Dresdner Transferbrief, Issue 2.16)
http://www.qucosa.de/fileadmin/data/qucosa/documents/20367/transferbrief_ausgabe... (pages 10-11)

Press Contact
Franziska Clauß
Press Officer
Phone: +49 351 458 82065, e-Mail: franziska.clauss@crt-dresden.de

Founded in 2006, the DFG Research Center for Regenerative Therapies Dresden (CRTD), Cluster of Excellence at the TU Dresden has passed the second phase of the Excellence Initiative which aims at promoting top-level research and improving the quality of German universities and research institutions. The goal of the CRTD is to explore the body's self-healing potential and to develop completely new, regenerative therapies for hitherto incurable diseases. The key areas of research include haematology and immunology, diabetes, neurodegenerative diseases and bone regeneration. At the moment, eight professors and ten group leaders are working at the CRTD – integrated into an interdisciplinary network of 87 members at seven different institutions within Dresden. In addition, 21 partners from industry are supporting the network. The synergies in the network allow for a fast translation of results from basic research to clinical applications.

www.crt-dresden.de

Franziska Clauß | idw - Informationsdienst Wissenschaft

More articles from Awards Funding:

nachricht Decoding cell communication
13.06.2019 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht ESJET printing technology for large area active devices awarded
11.04.2019 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-ever visualizations of electrical gating effects on electronic structure

Scientists have visualised the electronic structure in a microelectronic device for the first time, opening up opportunities for finely-tuned high performance electronic devices.

Physicists from the University of Warwick and the University of Washington have developed a technique to measure the energy and momentum of electrons in...

Im Focus: Megakaryocytes act as „bouncers“ restraining cell migration in the bone marrow

Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.

Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...

Im Focus: Artificial neural network resolves puzzles from condensed matter physics: Which is the perfect quantum theory?

For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.

Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...

Im Focus: Extremely hard yet metallically conductive: Bayreuth researchers develop novel material with high-tech prospects

An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".

The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...

Im Focus: Modelling leads to the optimum size for platinum fuel cell catalysts: Activity of fuel cell catalysts doubled

An interdisciplinary research team at the Technical University of Munich (TUM) has built platinum nanoparticles for catalysis in fuel cells: The new size-optimized catalysts are twice as good as the best process commercially available today.

Fuel cells may well replace batteries as the power source for electric cars. They consume hydrogen, a gas which could be produced for example using surplus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on UV LED Technologies & Applications – ICULTA 2020 | Call for Abstracts

24.06.2019 | Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

 
Latest News

How are pollen distributed in the air?

18.07.2019 | Life Sciences

A graphene superconductor that plays more than one tune

18.07.2019 | Physics and Astronomy

Plant viruses may be reshaping our world

18.07.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>